- Home
- IVVD
IVVD
Invivyd Inc.
as 05-09-2025 10:38am EST
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Upcoming Earnings Alert:
Get ready for potential market movements as Invivyd Inc. IVVD prepares to release earnings report on 15 May 2025.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 123.8M | IPO Year: | 2021 |
| Target Price: | $7.52 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.43 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.35 - $2.74 | Next Earning Date: | 05-15-2025 |
| Revenue: | $25,384,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 606.63% | Revenue Growth (next year): | 83.30% |
Latest Invivyd Inc. News
IVVD Breaking Stock News: Dive into IVVD Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025
Benzinga
18 days ago
What's Going On With Invivyd Stock On Monday?
GlobeNewswire
18 days ago
Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank
GlobeNewswire
a month ago
Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors
Zacks
2 months ago
Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates
GlobeNewswire
2 months ago
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights
Zacks
2 months ago
Are Investors Undervaluing Invivyd, Inc. (IVVD) Right Now?
GlobeNewswire
2 months ago
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
Compare IVVD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IVVD Invivyd Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.